Pharmaceutical manufacturer scaling contraception and women's health globally
Exeltis is a mid-sized pharma manufacturer operating across discovery, production, and commercial distribution with a footprint spanning 96 countries. The tech stack is heavily enterprise-focused (SAP S/4HANA, Veeva, Power BI), reflecting operational maturity in regulated manufacturing and supply-chain compliance. Hiring velocity is accelerating across sales (11 open roles) and finance (4), paired with active projects in product launch management and quality digitalization—signaling geographic expansion and portfolio scaling in contraception.
Exeltis manufactures and distributes pharmaceutical products and medical devices globally, with operations spanning discovery, development, production, and commercialization. The organization is part of a larger integrated health sciences group operating 20 facilities and 15 R&D centers across more than 50 countries, serving 1,150 customers in 96 countries. Core capability spans chemical manufacturing (chemo), branded pharmaceuticals (Exeltis brand), and biotech operations (mAbxience and Algenex). Current strategic focus includes expanding contraception and women's health product lines, localizing global strategy across territories, and optimizing sales coverage and procurement processes.
Exeltis runs SAP S/4HANA for ERP, Veeva for pharma-specific compliance and document management, SAP HANA for analytics, Power BI for dashboards, and SQL for data queries. Standard pharma stack reflects regulated manufacturing and GxP requirements.
Exeltis operates in 96 countries across six continents. Current hiring is active in Spain, Mexico, Germany, United States, Nicaragua, Chile, Peru, Philippines, Honduras, Dominican Republic, and Guatemala, signaling expansion in Latin America and Asia-Pacific regions.
Other companies in the same industry, closest in size